Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Ultrasonographic Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Patients With Spondyloarthritis

NCT04953871 is registered in ClinicalTrials.gov with Gunay ER as lead sponsor.

NCT NCT04953871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04953871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Ultrasonographic Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Patients With Spondyloarthritis
Lead sponsor
Gunay ER
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2017
Completion date
January 31, 2018
Enrollment
31 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anti-tumor necrosis factor drugs, enthesitis, spondyloarthritis